Therapy Areas
28 November 2022 - Diamyd Medical, a Sweden-based company that develops precision medicine therapies for Type 1 Diabetes, announced on Monday that the US Food and Drug Administration (FDA) has withdrawn the partial clinical hold on the confirmatory P...
28 November 2022 - Lyvgen Biopharma, a China-based global biotech company, announced on Sunday that it has entered into collaboration with United States-based Bristol Myers Squibb for an open label, phase two, multicentre, randomised trial of LVGN740...
28 November 2022 - Vial, a US-based, tech-enabled CRO providing next-generation clinical trial management services, announced on Sunday that it has added Marc Hoffmann, MD to the company's Advisory Board.In the new role, Dr Hoffmann will work cl...
25 November 2022 - - UK-based clinical stage biopharmaceutical company Aptorum Group Ltd. (NASDAQ: APM) (Euronext Paris: APM) is highlighting the recent publication of a joint effort for the validated analytical method developed for the determination...
25 November 2022 - - UK-based healthcare and pharmaceutical company SpectrumX is prepared to move forward with the next stage in clinical development of its respiratory drug candidate SPX-001 following a constructive scientific advice meeting with th...
25 November 2022 - - US-based biotechnology company AgeX Therapeutics, Inc. (NYSE American: AGE) received notification from the staff of the NYSE American that the Exchange has accepted a revised listing compliance plan from AgeX and has granted AgeX...
25 November 2022 - - US-based biopharmaceutical company Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) has received a Complete Response Letter from the US Food and Drug Administration regarding Spectrum's New Drug Application for poziotinib for t...